Clinical Trials Logo

Filter by:
NCT ID: NCT03060226 Completed - Clinical trials for Radiotherapy Side Effect

Prediction of Appearance of Late Cutaneous Side Effects After RadioTherapy

PAESCART
Start date: February 9, 2017
Phase: N/A
Study type: Interventional

Search for blood predictive marker (s) for cutaneous radiosensitivity

NCT ID: NCT03059823 Completed - Clinical trials for Metastatic Solid Tumors

A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors

Start date: November 15, 2016
Phase: Phase 1
Study type: Interventional

The primary goal of this Phase 1 study is to characterize the safety and tolerability of INCMGA00012 and establish the maximum tolerated dose (MTD) of INCMGA00012 administered on either every two week or every four week schedules of administration among patients with solid tumors. Pharmacokinetics, pharmacodynamics, and the anti-tumor activity of INCMGA00012 will also be assessed. The purpose of Amendment 5 is to obtain additional safety experience at the newly defined recommended Phase 2 dose of 500 mg every 4 weeks in patients with endometrial cancer, specifically either microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Additionally, every 3 week (Q3W) flat-dosing will be studied in an additional tumor agnostic cohort.

NCT ID: NCT03059758 Completed - Healthy Clinical Trials

Deductive Reasoning and Math Learning Difficulty

Start date: April 15, 2015
Phase: N/A
Study type: Interventional

Most studies to date that have examined the factors underlying math achievement in children have focused on basic numerical knowledge. Yet, math skills are clearly not limited to basic numerical knowledge and recent behavioral studies suggest a relationship between math and deductive reasoning skills. The goal of this study is to determine the neural mediators of this relationship using functional magnetic resonance imaging. The investigators will ask children from 8 to 14 to complete a standardized math achievement test, and measure their brain activity while they process deductive arguments. The investigators will then correlate brain activity during reasoning to individual math skills to identify the brain regions in which activity during reasoning is modulated by math skill.

NCT ID: NCT03059667 Completed - Clinical trials for Small Cell Lung Cancer

Immunotherapy as Second-line in Patient With Small Cell Lung Cancer

Start date: March 13, 2017
Phase: Phase 2
Study type: Interventional

Chemotherapy still constitutes the backbone of small-cell lung cancer (SCLC) therapy, particularly in the extensive disease (ED) stage (ED-SCLC). Despite the fact that a substantial complete response rate could be achieved in SCLC patients receiving etoposide - cisplatin doublet, cure remains the exception. Overall survival in patients receiving this combination is 10 months and progression free survival 6.3 months. At time of progression two options are hitherto accepted: reinduction of carboplatin - etoposide doublet or, for patients unfit for reinduction, topotecan single-drug regimen. However, in both clinical cases, median survival hardly achieves 33 weeks. Consistent data using anti - PDL1 (Programmed death-ligand 1) or anti PD1 (programmed cell death 1) antibodies suggest that they are active as single drug regimens in many malignant diseases. Taking into account the rich tumor infiltrating lymphocyte in pathological specimens of SCLC, we can hypothesize that experimental use of ATEZOLIZUMAB (MPDL3280A) in patients is ethical pending that it demonstrates activity in the second line setting.

NCT ID: NCT03058159 Completed - Healthy Clinical Trials

Sleep Inertia and Functional Connectivity

Start date: March 5, 2015
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the functional connectivity between the brain regions of the default mode network before and after a 40 min nap slot in the afternoon. The hypothesis is that connectivity between brain regions will be decreased after the nap as compared to before the nap.

NCT ID: NCT03058133 Completed - Healthy Clinical Trials

Gender in Face-Voice Integration

Face-Voice
Start date: May 20, 2016
Phase: N/A
Study type: Interventional

Bayesian models of perception represent a promising approach to describe information processing by the brain. Predictive coding hypothesizes a process in which top-down expectations are continuously compared across multiple hierarchical levels with bottom-up sensory inputs and the differences or error signals are propagated in a bottom-up direction. The investigators hypothesize that strong expectations, are best investigated in expert processes such as face and voice recognition in humans. Individuals in complex social systems need to extract socially relevant information in a fast and efficient manner; hence, the majority of humans constitute face, voice and gender experts. Nevertheless, linking such combined abilities to brain activity with regards to the predictive coding hypothesis has not been attempted.Our results suggest asymmetric contributions of visual and auditory signals to the gender classification task. This sensitive psychophysical procedure is implemented in a decoding approach using fMRI and multi-voxel pattern analysis (MVPA). The investigators plan to test whether cortical areas implicated in processing auditory and visual gender signals show similar asymmetries.

NCT ID: NCT03058081 Completed - COPD Exacerbation Clinical Trials

Effect of High Flow Nasal During Exercise in COPD Patients

AiRehab
Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. High flow ventilation in reducing work of breathing and dyspnea may improve exercise tolerance. The aim of this study is to carry out the acute effect of high flow nasal cannula on exercise endurance in post-exacerbation copd patients

NCT ID: NCT03057977 Completed - Heart Failure Clinical Trials

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Start date: March 6, 2017
Phase: Phase 3
Study type: Interventional

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

NCT ID: NCT03057288 Completed - Rectal Neoplasms Clinical Trials

Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer

FIDECHO
Start date: February 3, 2017
Phase: N/A
Study type: Interventional

It is a multicenter prospective observational study including consecutive patients with esophageal tumor or rectum with indication for radiotherapy The main objective of this study is to evaluate the feasibility of fiducial markers placement under EUS guidance. The evaluation criteria are: - Success rate evaluation of the placement of two markers : one in the upper part of the tumor and one in the lower part. Success of the procedure will be evaluated by the endoscopist at the end of the procedure. Pictures of the markers will objectify the good placement of the markers. - Complications (early within 24 hours and late complications) such as pain, bleeding, perforation, infection, migration of the markers - The length of the procedure - The costs (procedure, hospitalization) - The clinical efficacy, by studying the decrease of the estimated target volume, the decrease of the dose delivered to the healthy tissue and the improvement of positioning of the irradiation beams by the radiotherapy technician - The presence of the markers at the end of the radiotherapy

NCT ID: NCT03056612 Completed - Clinical trials for Liver Cirrhosis With Acute Decompensation

Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study

PREDICT
Start date: March 31, 2017
Phase:
Study type: Observational

The aim of this study is to assess prospectively the critical period prior to the development of Acute-on-Chronic Liver Failure (ACLF) (1), to uncover mechanistic and pathophysiological processes associated with the development and clinical course of ACLF (2) and to identify the precipitating events of ACLF (3).